LUNG CANCER RESEARCH FOUNDATION logo

LCRF – Boehringer Ingelheim Early Investigator Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer

LUNG CANCER RESEARCH FOUNDATION

Funding Amount

Varies

Deadline

Rolling / Open

Grant Type

foundation

Overview

LCRF – Boehringer Ingelheim Early Investigator Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer

Funder: Lung Cancer Research Foundation (LCRF) and Boehringer Ingelheim
Geographic Scope: International (scientists around the world)
Focus Areas: Innovative treatment approaches for HER2-driven lung cancer

Description

Annual early investigator award supporting innovative research on treatment strategies for HER2-driven lung cancer. Recipients are selected from hundreds of applicants.

Eligibility

Open to early career scientists, physicians, students, and fellows working on HER2-driven lung cancer research.

    Contact

  • Phone: (212) 588-1580
  • Email: info@LCRF.org
  • Mailing Address: PO Box 780990, Philadelphia, PA 19178-0990

Focus Areas & Funding Uses

Fields of Work

cancerscience-research

Categories

Browse similar grants by category

Related Grants

Similar grants from this funder and related organizations

Ready to apply for LCRF – Boehringer Ingelheim Early Investigator Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.